Science Explorer Back to mapMap
Discussion
Researcher · Inserm · France

Lionel Apétoh

Lionel Apétoh publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.

ORCID 0000-0002-2774-438X OpenAlex
World rank
#38,379
of 7,710,434 ranked researchers
Rank in France
#4,647
of 324,115
Works
234
Citations
38k
Citations per work
163.3
h-index
71
i10-index 123Top 1.4% in Immunology
Lionel Apétoh

What does Lionel Apétoh research?

Lionel Apétoh's work is mostly in Immunology and Microbiology (49%), Medicine (24%), Biochemistry, Genetics and Molecular Biology (11%).

Life Sciences: 140 works · 60.0% of their workImmunology and Microbiology: 114 works · 48.7% of their workImmunology: 114 works · 48.7% of their workBiochemistry, Genetics and Molecular Biology: 26 works · 11.3% of their workMolecular Biology: 20 works · 8.4% of their workCancer Research: 7 works · 2.9% of their workHealth Sciences: 56 works · 23.8% of their workMedicine: 56 works · 23.8% of their workOncology: 47 works · 20.2% of their workEpidemiology: 5 works · 2.1% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 1.5% of their workEverything else: 38 works · 16.2% of their workTHEIR WORKLionel Apétoh234works
Life Sciences60%Health Sciences24%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology11448.7%
    2. Biochemistry, Genetics and Molecular Biology2611.3%
    1. Medicine5623.8%
  3. Everything else3816.2%
  1. 1Immunology49% of their works
  2. 2Oncology20% of their works
  3. 3Molecular Biology8% of their works
  4. 4Cancer Research3% of their works
  5. 5Epidemiology2% of their works
  6. 6Radiology, Nuclear Medicine and Imaging2% of their works

Research topics

Which keywords describe Lionel Apétoh's research?

The keywords of their largest research topics: Cancer Immunotherapy, Immunity, Natural Killer Cells, NK Cell Recognition, Immune Checkpoint Blockade, PD-1 and PD-L1, Antigen Presentation and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Immunotherapy1013 topics
  2. Immunity852 topics
  3. NK Cell Recognition741 topic
  4. Natural Killer Cells741 topic
  5. Immune Checkpoint Blockade651 topic
  6. PD-1 and PD-L1651 topic
  7. Antigen Presentation641 topic
  8. Dendritic Cells641 topic
  9. Inflammation352 topics
  10. Foxp3271 topic
  11. TGF-ß271 topic
  12. CAR T Cells221 topic
  13. Chimeric Antigen Receptor221 topic
  14. Activation211 topic
  15. Macrophage211 topic
  16. CD47151 topic
  17. apoptotic cells151 topic
  18. Inflammasome141 topic
  19. NLRP3141 topic

Where does Lionel Apétoh work?

Lionel Apétoh's main affiliation in the publication record is Inserm, France.

How many publications and citations does Lionel Apétoh have?

OpenAlex counts 234 works and 38,218 citations for Lionel Apétoh, an h-index of 71, ranking #38,379 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lionel Apétoh. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.